🌟 Join this upcoming webinar with Claritas Rx for a fireside chat featuring Mike McDole from Aveo, an oncology-focused biopharmaceutical company. In this discussion, the featured speakers will explore the challenges and opportunities within trade operations and customer base expansion. 💡 Learn more and register here: https://buff.ly/40pd4my #PatientData #PatientSupport #PatientManagement
Xtalks’ Post
More Relevant Posts
-
Redesigning for speed: Addressing life cycle compression in biopharma: Biopharmaceutical companies that make bold moves to address life cycle compression, including reshaping portfolios and operations for agility and decisiveness, can capture value from innovation. http://dlvr.it/T446Xh
-
How much does the cost of failed trials financially impact biopharmaceutical organizations? Our latest white paper explores what causes the early termination of clinical studies and what sponsors can do to improve their pipeline productivity and prevent ceasing development: https://ow.ly/6ZkK30sBgvW #SyneosHealth
-
-
Hear from Veralox and other biopharmaceutical companies about their experiences working with #Calyx and how our #MedicalImaging expertise is helping their #ClinicalTrials succeed. https://lnkd.in/gQmdAmd5
-
Hear from Veralox and other biopharmaceutical companies about their experiences working with #Calyx and how our #MedicalImaging expertise is helping their #ClinicalTrials succeed. https://lnkd.in/ggF3N4X7
-
How much does the cost of failed trials financially impact biopharmaceutical organizations? Our latest white paper explores what causes the early termination of clinical studies and what sponsors can do to improve their pipeline productivity and prevent ceasing development: https://ow.ly/pH0i30sBg1r #SyneosHealth
-
-
Engineered Scientific Data is the Force Multiplier for AI
Join us along with our partner Semantic Web Company (SWC) for our joint webinar in December while we address several crucial aspects of maximizing the value of scientific data in the biopharmaceutical industry. Register Today! https://lnkd.in/gfz2BeiU
-
-
Discover key insights on navigating self-commercialisation across Europe, shared by Mike Ryan in the Spring 2024 issue of European Biopharmaceutical Review (EBR). Read on here: https://lnkd.in/eExnm8Np #biopharma #commercialization #strategy #europe #launches EVERSANA EVERSANA INTOUCH
What do brands need to know to successfully navigate self-commercialisation across Europe? Mike Ryan recently shared his insights in the Spring 2024 issue of European Biopharmaceutical Review (EBR). Read his insights here: https://ow.ly/L8Cc50QNSPK
-
-
What does the future hold for biopharmaceutical industry deals in 2024? Dive in to the #SyneosHealth Dealmakers’ Intentions Survey and learn more about the expectations of biopharma decision-makers in this forward-looking measure of industry dealmaking activity. Find out more: https://lnkd.in/djvGVgBC #SyneosHealthLife #WorkHereMattersEverywhere #ClinicalCareers #SyneosHealth #ClinicalSolutions #2024HealthTrends
-
-
Wanting to learn more about how to reduce the risk of early study terminations due to poor enrollment and portfolio strategy shifts? Check out this informative Syneos Health whitepaper by Robert Liebman: https://lnkd.in/eRDY7g76
How much does the cost of failed trials financially impact biopharmaceutical organizations? Our latest white paper explores what causes the early termination of clinical studies and what sponsors can do to improve their pipeline productivity and prevent ceasing development: https://lnkd.in/gQqZhbgx #SyneosHealth
